ENVISTA HOLDINGS CORPORATION Proceeds from Sale of Equity Method Investments
ENVISTA HOLDINGS CORPORATION (NVST) reported Proceeds from Sale of Equity Method Investments of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfEquityMethodInvestments · last filed 2026-02-12
- ENVISTA HOLDINGS CORPORATION proceeds from sale of equity method investments for the quarter ending 2025-12-31 was $0.00.
- ENVISTA HOLDINGS CORPORATION proceeds from sale of equity method investments for the quarter ending 2024-12-31 was $0.00.
- ENVISTA HOLDINGS CORPORATION proceeds from sale of equity method investments for the quarter ending 2024-09-27 was $0.00.
- ENVISTA HOLDINGS CORPORATION proceeds from sale of equity method investments for the quarter ending 2023-12-31 was $0.00.
- ENVISTA HOLDINGS CORPORATION proceeds from sale of equity method investments for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- ENVISTA HOLDINGS CORPORATION proceeds from sale of equity method investments for fiscal 2024 was $400.00K, a 96.26% decline from fiscal 2023.
- ENVISTA HOLDINGS CORPORATION proceeds from sale of equity method investments for fiscal 2023 was $10.70M.
- ENVISTA HOLDINGS CORPORATION proceeds from sale of equity method investments for fiscal 2022 was $0.00.
| Period end | Proceeds from Sale of Equity Method Investments 3 month | Proceeds from Sale of Equity Method Investments 6 month | Proceeds from Sale of Equity Method Investments 9 month | Proceeds from Sale of Equity Method Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $0.00 10-K · filed 2026-02-12 | ||
| 2025-09-26 | $0.00 10-Q · filed 2025-10-30 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | $400.00K 10-K · filed 2026-02-12 | |
| 2024-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $400.00K 10-Q · filed 2025-10-30 | ||
| 2024-06-28 | $400.00K 10-Q · filed 2024-08-07 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | $10.70M 10-K · filed 2026-02-12 | |
| 2023-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $10.70M 10-Q · filed 2024-10-30 | ||
| 2023-06-30 | $10.70M 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $0.00 derived: sum of 2 quarters · filed 2025-02-13 | $0.00 10-K · filed 2025-02-13 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | ||
| 2022-07-01 | $0.00 10-Q · filed 2023-08-02 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DENTSPLY SIRONA Inc. (XRAY) | United States | $1.900B | -3.87 |